Conclusion
Available evidence suggests that we can not dismiss the potential value of nutriceuticals in disease and inhibition of atherosclerosis. Epidemiologic data suggest that antioxidant supplementation may be associated with a reduced risk of clinical events from atherosclerosis; howere, interventional trials only support a role for vitamin E in this regard. Many studies suggest that a link between fruit and vegetables in diet or the amounts of plasma antioxidant vitamins (ascorbic acid, tocopherols and carotenoids) and risk of death from cancer or coronary heart disease. The usefulness of antioxidant for prevention of cardiovascular disease is yet to be proven. However, studies offer important insights that together with the development of methods to identify individuals most likely to benefit, provide hope to clinicians seeking to use antioxidant vitamins with safety and efficacy for the treatment and prevention of cardiovascular disease. Only continued investigation into the mechanism (s) of action of candidate agents will determine whether they hold promise as a therapeutic intervention and only then, they can be recommended routinely to the patients. Thus, nutriceuticals are becoming more widely accepted as an adjunct to conventional therapies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sies, H. and Stahl, W. (1995). Vitamin E and C, β-Carotene, and other carotoenoids as antioxidants. Am. J. Clin. Nutr. 62, 1315S-21S.
Rimm, E.B. and Stampfer, M.J. (2000). Antioxidants for vascular disease. Med. Clin. North America 84, 239–49.
Keaney, J.E., Simon, D.I. and Freedman, J.E. (1999). Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB. J. 13, 965–76.
Hodis, H.N., Mack, W.J. and LaBree, L.et al. (1995). Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273, 1849–54.
Stepens, N.G., Parsons, A. and Schofield, P.M.et al. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781–6.
Kritchevsky, S.B., Shimakawa, T. and Tell, G.S.,et al. (1995) Dietary antioxidants and carotid artery wall thickness: the ARIC study. Circulation 92, 2142–50.
Hoeing, B., Arakawa, N., Kohler, C. and Drexler, H. (1998) Vitamin C improves endothelial functions of conduit arteries in patients with chronic heart failure. Circulation 97, 363–8.
Solzbach, U., Just, H., Jeserich, M. and Hornig, B. (1997) Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 96, 1513–9.
Ting, H.H., Creager, M.A. and Ganz, P.et al. (1997) Vitamin C improves endothelium-dependent vasodilatation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 95, 2617–22.
Yokoyama, H., Lingle, D.M., and Crestanello, J.A.,et al. (1996) Coenzyme Q10 protects coronary endothelial function from ischaemia reperfusion injury via an antioxidant effect. Surgery 120, 189–96.
Stahl, W. and Sies, H. (1996) Lycopene: a biologically important corotenoid for humans? Arch. Biochem. Biophys. 336, 1–9.
Agarwal, S. and Rao, A.V. (1998) Tomato lycopene and low density topoprotein oxidation: a human dietary intervention study. Lipids 33, 981–4.
Kohlmeir, L., Kark, J.D. and Gomez-Garcia, E.et al. (1997) Lyropene and myocardial infarction risk in the EURAMIC Study. Am. J. Epidemiol. 146, 618–26.
Stampfer, M.J., Hennekens, C.H., Manson, J.E., Colditz, G.A., Rosner, B. and Willet, W.C. (1993) Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328, 1444–9.
Albanes, D., Heinohen, O.P. and Taylor, P.R.et al. (1996) Alpha-tocopherol, Betacarotene Cancer Prevention Study: Effects of base-line characteristics and study compliance. J. Natl. Cancer Inst. 88, 1560–70.
Omenn, G.S., Goodman, G.E. and Thornquist, M.D.et al. (1996) Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retionol Efficacy Trial. J. Natl. Cancer Inst. 88, 1550–9.
Formica, J.V. and Regelson, W. (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 33, 1061–80.
Hollman, P.C.H. and Katan, M.B. (1997) Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother. 51, 305–10.
Hertog, M.G.L., Feskens, E.J.M., Hollman, P.C.H., Katan, M.B. and Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342, 1007–11.
Potter, S.M. (1996) Soy protein and serum lipids. Curr. Opin. Lipidol. 7, 260–4.
Laplaud, P.M., Lel Ubre, A. and Chapman, M.J. (1997) Antioxidant actions of vaccinium myrtillus extract on human low density lipoproteins in vitro: Initial observations. Fundam. Clin. Pharmacol. 11, 35–40.
Stromer, F.C., Reistad, R. and Alexander, J. (1993) Glycyrrhizic acid in liquorice: evaluation of health hazard. Food Chem. Toxicol. 31, 303–12.
Cooke, J.P. and Dzau, V.J. (1997) Nitric oxide synthase: role in the genesis of vascular disease. Ann. Rev. Med. 48, 489–509.
Cooke, J.P. and Tasao, P.A. (1997) Arginine: a new therapy for atherosclerosis? Circulation 95, 311–2.
Cooke, J.P. and Tsao, P.S. (1997) Endothelial alterations in atherosclerosis: the role of nitric oxide. In Webb D, Vallance P, eds, Endothelial Functions in Hypertension. Heidelberg: Springer-Verlag, 29–38.
Lerman, A., Burnett, J.C., Higeno, S.T., McKinley, L.J. and Holmes, D.R. (1998) Long term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation 97, 2123–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kharb, S., Singh, V. Nutriceuticals in health and disease prevention. Indian J Clin Biochem 19, 50–53 (2004). https://doi.org/10.1007/BF02872389
Issue Date:
DOI: https://doi.org/10.1007/BF02872389